NPM1 and acute myeloid leukemia: Therefore, therapy based on the interference with NPM oligomerization might be beneficial for AML patients with NPM1 mutation, as only NPMmut-consisting oligomers would be inhibited under optimal conditions and NPMwt could retain its function.